BCL2 and prostate carcinoma: Nevertheless, in PC3 prostate cancer cells, mangiferin substantially boosts the expression of miR‐182, while enormously eliminating Bcl‐2‐expression, and stimulates caspase‐3 activity and apoptosis (Khoobchandani et al., 2021).